YOLFTbeta
Mayne Pharma Group Ltd

Mayne Pharma Group Ltd

MYX · AU · Healthcare / Medical Distribution

3.30AUD-0.09 (-2.65%)

Price History

Full chart

Market Stats

Previous Close3.39
Open3.34
Day Range3.29 – 3.36
52-Week Range2.04 – 6.50
Volume438.53K
Market Cap233.39M
P/E (TTM)7.31
Forward P/E263.16
EPS0.39
Dividend Yield0.00%
Beta1.01
50-Day Avg3.03
200-Day Avg2.72

About

Mayne Pharma Group Limited, a specialty pharmaceutical company, focuses on the commercialization of women's health and dermatology pharmaceuticals in Australia, New Zealand, the United States, Canada, Europe, Asia, and internationally. It operates through three segments: Women's Health, Dermatology, and International. The company provides oral drug delivery systems, as well as contract development and manufacturing services to third party customers. It also distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

Company Details

  • SectorHealthcare
  • IndustryMedical Distribution
  • CEOMr. Aaron Gray
  • Employees363
  • Headquarters1538 Main North Road, Salisbury South, SA, Australia, 5106, Australia
  • Websitehttps://www.maynepharma.com

Leadership

  • Mr. Aaron GrayChief Executive Officer
  • Mr. Griffin D. BuchananChief Financial Officer
  • Dr. Thomas Duthy M.B.A., Ph.D.Manager of Investor Relations
  • Ms. Kimberly Parker J.D.Executive VP & General Counsel
  • Mr. Brant SchofieldExecutive Vice President of Corporate Development · b. 1966
  • Ms. Kate SurdezVP & Global Head of Human Resources
  • Mr. Daniel MoorePresident of DistributeRx
  • Dr. Frank Casty M.D.Executive VP, Global Head of R&D and Chief Medical Officer
  • Mr. Tony RamyExecutive Vice President of Women's Health
  • Mr. Brenton WalterFinancial Controller

Financials

Income Statement

Currency: AUD2006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue-140.11K820.81K1.04M37.04M48.77M51.08M82.26M142.18M140.32M267.28M572.60M530.31M525.21M456.99M400.78M157.15M183.59M388.15M408.10M383.68M
Growth (%)--+485.83%+26.69%+3462.33%+31.65%+4.74%+61.05%+72.84%-1.31%+90.47%+114.23%-7.38%-0.96%-12.99%-12.30%-60.79%+16.82%+111.43%+5.14%-5.98%
Cost of Revenue----19.13M26.86M29.34M44.44M68.20M61.43M115.25M323.99M346.14M316.16M316.05M273.76M133.40M156.75M169.62M160.82M191.47M
Gross Profit-140.11K820.81K1.04M17.92M21.91M21.74M37.82M73.98M78.89M152.03M248.61M184.17M209.05M140.94M127.02M23.75M26.84M218.53M247.27M192.21M
Gross Margin-100.00%100.00%100.00%48.37%44.92%42.55%45.98%52.03%56.22%56.88%43.42%34.73%39.80%30.84%31.69%15.11%14.62%56.30%60.59%50.10%
Operating Expense-2.10M5.05M6.20M17.10M22.72M19.20M31.84M41.61M61.70M96.53M126.34M147.05M179.87M153.07M125.65M145.62M213.28M357.59M270.87M226.49M
Operating Income--1.96M-4.23M-5.16M813.88K-817.00K2.53M5.98M32.37M17.19M55.50M122.26M37.12M29.17M-12.13M1.36M-121.88M-186.44M-139.06M-23.59M-34.28M
Operating Margin--1401.80%-515.59%-496.68%2.20%-1.68%4.96%7.26%22.77%12.25%20.77%21.35%7.00%5.55%-2.65%0.34%-77.56%-101.56%-35.83%-5.78%-8.94%
EBITDA--1.82M-3.45M-4.10M8.70M8.06M13.37M8.93M42.24M31.69M73.71M201.12M-71.08M-241.16M-34.03M-182.40M-78.88M-193.80M-116.93M42.08M29.40M
EBITDA Margin--1298.25%-420.37%-394.13%23.47%16.53%26.17%10.86%29.71%22.58%27.58%35.12%-13.40%-45.92%-7.45%-45.51%-50.20%-105.57%-30.12%10.31%7.66%
Net Income--1.82M-3.47M-3.76M3.25M1.68M6.15M-2.84M21.29M7.76M37.35M88.57M-133.98M-279.20M-92.79M-208.42M-281.29M117.25M-174.23M-93.84M24.47M
Net Income Margin--1301.80%-423.09%-361.71%8.78%3.44%12.05%-3.46%14.97%5.53%13.98%15.47%-25.27%-53.16%-20.30%-52.00%-179.00%63.87%-44.89%-22.99%6.38%
R&D-822.88K2.24M3.15M5.29M5.97M4.02M3.98M4.55M5.59M8.73M8.28M12.30M25.80M21.75M18.91M12.21M15.73M20.24M19.47M20.75M
R&D as % of Total Revenue-587.30%273.32%302.51%14.29%12.25%7.87%4.84%3.20%3.98%3.27%1.45%2.32%4.91%4.76%4.72%7.77%8.57%5.21%4.77%5.41%
Interest Expense00001.48M1.81M28.00K2.31M4.35M5.95M2.49M11.52M15.82M18.06M16.77M13.30M11.53M10.45M4.70M5.01M5.30M
Interest Expense % of Total Revenue-0.00%0.00%0.00%4.00%3.72%0.05%2.80%3.06%4.24%0.93%2.01%2.98%3.44%3.67%3.32%7.33%5.69%1.21%1.23%1.38%

Balance Sheet

Currency: AUD2006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets29.00K15.51M11.69M8.04M71.15M53.68M53.93M233.39M265.82M528.95M1.56B1.91B1.83B1.64B1.83B1.46B1.29B1.25B1.14B1.01B909.45M
Total Liabilities7.00K996.16K254.85K331.53K45.60M29.50M23.33M112.50M106.55M206.74M1.18B602.50M595.35M622.26M782.87M691.61M730.81M612.99M688.99M644.32M518.50M
Total Equity21.00K14.51M11.44M7.70M25.55M24.17M30.60M120.89M159.27M310.87M363.75M1.30B1.23B1.01B1.04B768.36M564.77M634.36M454.19M370.28M390.94M
Cash29.00K15.30M11.53M7.94M19.71M5.81M11.60M18.94M14.81M59.20M47.48M63.03M87.31M89.00M137.78M97.98M96.67M92.62M110.07M59.84M82.25M
Total Debt-8.89K5.56K2.22K8.61M2.34M-46.70M48.03M64.98M77.67M340.25M374.19M369.38M398.05M346.82M413.67M47.51M38.82M41.27M43.20M
Net Debt--15.29M-11.53M-7.93M-11.09M-3.47M-11.60M27.76M33.22M2.56M30.19M277.22M286.88M280.38M260.26M248.84M316.99M-45.11M-71.25M-18.57M-39.05M

Cash Flow

Currency: AUD2006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow--1.24M-3.03M-3.59M10.26M4.09M13.39M6.84M26.14M22.42M53.50M-15.24M121.50M106.61M99.78M47.26M-7.21M-42.71M-15.30M17.47M15.62M
Investing Cash Flow1.00K-61.94K-10.29K-4.34K-18.78M-2.10M-2.55M-125.54M-50.81M-95.50M-83.80M-1.10B-118.35M-91.69M-55.87M-49.25M-28.53M473.49M53.45M-68.07M10.00M
Financing Cash Flow30.00K16.58M-736.48K-20.30M-14.67M-5.20M126.18M19.89M115.11M17.99M1.13B20.18M-15.55M4.52M-28.83M27.60M-431.89M-19.85M-556.00K-3.23M
Capital Expenditure061.94K10.29K4.34K398.56K2.10M2.55M21.06M4.20M4.17M29.59M104.42M54.18M11.91M47.12M25.10M11.85M219.59M20.86M12.28M2.94M
Free Cash Flow--1.30M-3.04M-3.59M9.86M1.98M10.84M-14.21M21.93M18.25M23.91M-119.65M67.32M94.69M52.66M22.16M-28.47M-262.30M-36.16M5.19M12.67M
Dividends Paid----10.72M4.52M-45.68M11.08M54.33M0858.48M--45.29M45.29M45.29M45.29M0--
FCF to OCF-105.00%100.34%100.12%96.11%48.51%80.97%-207.66%83.92%81.38%44.70%785.28%55.41%88.83%52.78%46.89%395.10%614.11%236.35%29.73%81.14%
Dividend Paid to FCF----108.78%228.10%--321.37%50.54%297.78%0.00%-717.47%--86.01%204.40%-159.08%-17.27%0.00%--

Earnings

Report DateDec 31, 2006Mar 31, 2007Jun 30, 2007Sep 30, 2007Dec 31, 2007Mar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Jun 30, 2009Sep 30, 2009Dec 31, 2009Mar 31, 2010Jun 30, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Sep 30, 2012Dec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Feb 26, 2016Mar 31, 2016Aug 26, 2016Sep 30, 2016Feb 24, 2017Mar 31, 2017Aug 25, 2017Sep 30, 2017Feb 22, 2018Aug 23, 2018Feb 21, 2019Aug 22, 2019Feb 20, 2020Aug 20, 2020Feb 23, 2021Aug 26, 2021Feb 24, 2022Aug 26, 2022Feb 28, 2023Aug 31, 2023Feb 25, 2024Aug 22, 2024Feb 25, 2025Aug 20, 2025Dec 31, 2025
EPS Estimate------------------------------------0.03-0.00-0.00-0.00-0.000.000.000.000.00---0.03-0.40-0.01--0.57-0.92-0.27-0.46--
EPS Actual-0.15-0.15-0.15-0.15-0.33-0.16-0.33-0.16-0.33-0.18-0.35-0.180.180.090.180.090.080.040.080.040.290.140.290.14-0.12-0.03-0.01-0.26-0.40-0.11-0.11-0.02-0.02-0.05-0.01--0.120.030.00-0.18-0.01-0.05-0.12-0.02-0.03-0.13-1.570.000.000.00-0.25-0.89-0.18
Surprise-------------------------------------21.88%--------------20.00%92.50%-1081.82%-100.00%100.00%100.00%46.00%--
Timing----------------------------------------------------After-hoursPre-marketPre-marketAfter-hours---After-hours-

Key Statistics & Ratios

Market Cap233.39M
Enterprise Value204.77M
Trailing P/E7.31
Forward P/E263.16
PEG Ratio2.52
Price / Sales0.61
Price / Book0.62
EPS0.39
Book Value4.99
Revenue (TTM)383.68M
Gross Profit (TTM)248.07M
EBITDA33.10M
Profit Margin6.38%
Operating Margin-2.94%
Return on Equity8.20%
Return on Assets-1.73%
Shares Outstanding81.89M
Shares Float43.79M
Beta1.01
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
24.74%
Insiders
22.61%
Retail / Other
52.65%

Top Fund Holders

  • DFA International Small Cap Value Portfolio
    23.02M1.37%
  • Vanguard International Stock Index-Total Intl Stock Indx
    22.38M1.33%
  • Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund
    10.52M0.63%
  • DFA Asia Pacific Small Company Series
    9.52M0.57%
  • iShares MSCI EAFE Small Cap ETF
    6.51M0.39%
  • Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index
    4.45M0.26%
  • DFA International Core Equity Portfolio
    3.94M0.23%
  • College Retirement Equities Fund-Stock Account
    3.62M0.22%
  • Schwab Strategic Tr-Schwab International Small Cap Equity ETF
    2.33M0.14%
  • TIAA-CREF Funds-Quant International Small Cap Equity Fund
    2.30M0.14%

Dividends

20231×
0.54Jan 18, 2023
20111×
0.14Mar 3, 2011
20101×
0.29Oct 25, 2010

Stock Splits

  • Jan 17, 20231:20